Cumulative Recurrence Rate and Risk Factors for Recurrent Abdominal Wall Endometriosis after Surgical Treatment in a Single Institution
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: This study aimed to evaluate the cumulative recurrence rate and risk factors for recurrent abdominal wall endometriosis(AWE) after surgical treatment. Materials and Methods: A retrospective cohort study was conducted at a single gynecological surgery center between January2004 and December 2020. Patients who were surgically treated and followed up for at least 6 months after surgery were selected. Results: Eighteen patients with pathologically diagnosed AWE were included in this study. The median follow-up duration was22.5 months (range, 6–106). The median age was 37 years (range, 22–48), and 33.3% of the patients were nulliparous. Among thepatients included in our study, 55.6% complained of a mass with cyclic pain, and 27.8% had a palpable mass. In addition, 22.2% ofpatients experienced recurrence with 17.5±9.7 months of mean time to recurrence. The cumulative recurrence rates at 24 and 60months after surgical treatment of AWE were 23.8% and 39.1%, respectively. There were no statistically significant risk factors for therecurrence of AWE, including postoperative medical treatment. Conclusion: The recurrence rate of AWE appears to be correlated with the follow-up duration. There was no statistically significantrisk factor for the recurrence of AWE. Unlike ovarian endometriosis, postoperative hormonal treatment does not seem to lower therecurrence of AWE. The findings of the current study may help healthcare providers in counselling and managing patients with AWE.
Abstract
Purpose: This study aimed to evaluate the cumulative recurrence rate and risk factors for recurrent abdominal wall endometriosis(AWE) after surgical treatment. Materials and Methods: A retrospective cohort study was conducted at a single gynecological surgery center between January2004 and December 2020. Patients who were surgically treated and followed up for at least 6 months after surgery were selected. Results: Eighteen patients with pathologically diagnosed AWE were included in this study. The median follow-up duration was22.5 months (range, 6–106). The median age was 37 years (range, 22–48), and 33.3% of the patients were nulliparous. Among thepatients included in our study, 55.6% complained of a mass with cyclic pain, and 27.8% had a palpable mass. In addition, 22.2% ofpatients experienced recurrence with 17.5±9.7 months of mean time to recurrence. The cumulative recurrence rates at 24 and 60months after surgical treatment of AWE were 23.8% and 39.1%, respectively. There were no statistically significant risk factors for therecurrence of AWE, including postoperative medical treatment. Conclusion: The recurrence rate of AWE appears to be correlated with the follow-up duration. There was no statistically significantrisk factor for the recurrence of AWE. Unlike ovarian endometriosis, postoperative hormonal treatment does not seem to lower therecurrence of AWE. The findings of the current study may help healthcare providers in counselling and managing patients with AWE.
참고문헌 (21)
- Bulun SE, "Endometriosis", N Engl J Med, 360, pp.268~279 (2009)
- Hirata T, "Extra-pelvic endometriosis : a review", Reprod Med Biol, 19, pp.323~333 (2020)
- Zhao X, "Abdominal wall endometriomas", Int J Gynaecol Obstet, 90, pp.218~222 (2005)
- Chang Y, "Abdominal wall endometriomas", J Reprod Med, 54, pp.155~159 (2009)
- Ecker AM, "Abdominal wall endometriosis : 12 years of experience at a large academic institution", Am J Obstet Gynecol, 211, pp.363.e1~363.e5 (2014)
- Horton JD, "Abdominal wall endometriosis : a surgeon’s perspective and review of 445 cases", Am J Surg, 196, pp.207~212 (2008)
- Matalliotakis M, "Abdominal and perineal scar endometriosis : retrospective study on 40 cases", Eur J Obstet Gynecol Reprod Biol, 252, pp.225~227 (2020)
- Khan Z, "Risk factors, clinical presentation, and outcomes for abdominal wall endometriosis", J Minim Invasive Gynecol, 24, pp.478~484 (2017)
- Blanco RG, "Abdominal wall endometriomas", Am J Surg, 185, pp.596~598 (2003)
- Francica G, "Abdominal wall endometriomas near cesarean delivery scars : sonographic and color doppler findings in a series of 12 patients", J Ultrasound Med, 22, pp.1041~1047 (2003)
- Gunes M, "Incisional endometriosis after cesarean section, episiotomy and other gynecologic procedures", J Obstet Gynaecol Res, 31, pp.471~475 (2005)
- Rao R, "Post-caesarean incisional hernia or scar endometrioma?", Surgeon, 4, pp.55~56 (2006)
- Goel P, "Scar endometriosis-a series of six patients", Int J Surg, 9, pp.39~40 (2011)
- Lopez-Soto A, "Cutaneous endometriosis : presentation of 33 cases and literature review", Eur J Obstet Gynecol Reprod Biol, 221, pp.58~63 (2018)
- Purvis RS, "Cutaneous and subcutaneous endometriosis. Surgical and hormonal therapy", J Dermatol Surg Oncol, 20, pp.693~695 (1994)
- Rani PR, "Endometriosis in abdominal scars--review of 27 cases", Int J Gynaecol Obstet, 36, pp.215~218 (1991)
- Angioni S, "Dienogest. A possible conservative approach in bladder endometriosis. Results of a pilot study", Gynecol Endocrinol, 31, pp.406~408 (2015)
- Harada M, "Dienogest, a new conservative strategy for extragenital endometriosis : a pilot study", Gynecol Endocrinol, 27, pp.717~720 (2011)
- Agarwal S, "Dienogest for the treatment of deep endometriosis : case report and literature review", J Obstet Gynaecol Res, 41, pp.309~313 (2015)
- Leone Roberti Maggiore U, "Urinary incontinence and bladder endometriosis : conservative management", Int Urogynecol J, 26, pp.159~162 (2015)
- Barra F, "Long-term administration of dienogest for the treatment of pain and intestinal symptoms in patients with rectosigmoid endometriosis", J Clin Med, 9, pp.154~ (2020)